실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-11 · 마지막 7월 13일
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Robatumumab (Robatumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
ADCBiologicstaleDualityBio Inc.Phase 2

DB-1310 (DB-1310)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
AntibodystaleMerck Sharp & Dohme LLCPhase 2

Dalotuzumab (Dalotuzumab)

Rectal Neoplasms · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+2
효능 ORR 21.6%임상시험 2상태 ACTIVE
AntibodystaleEli Lilly and CompanyPhase 2

cixutumumab (IMC-A12, IMC-A12 (cixutumumab))

Non-Small Cell Lung Cancer · Colon Cancer

#ColonCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 37.9%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab + Paclitaxel (Cetuximab + Paclitaxel)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 41.6%임상시험 2상태 DISCONTINUED
ADCBiologicstaleEMD Serono Research & Developme…Phase 2

M6223 (M6223)

Metastatic Solid Tumors · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleEli LillyPhase 2

cetuximab, cisplatin (cetuximab, cisplatin)

Head and Neck Cancer · Breast Neoplasm

#BreastNeoplasm#Antibody#Phase2#항체#면역항체+3
효능 ORR 73%임상시험 2상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab, Capecitabine (Cetuximab, Capecitabine)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 2상태 ACTIVE
AntibodystaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#항체#면역항체+4
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87 + HLX22 (HLX87 + HLX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystaleTakedaPhase 2

Mezagitamab (Mezagitamab)

Relapsed and/or Refractory Multiple Myeloma (RRMM) · FRα

#FR#Antibody#Phase2#항체#면역항체+4
효능 ORR 25%임상시험 2상태 ACTIVE
ADCBiologicstaleJiangsu HengRui Medicine Co., L…Phase 2

SHR-1316 (SHR-1316)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, 89Zr-DFO-daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 2상태 DISCONTINUED
AntibodystaleJanssenPhase 1

daratumumab (Darzalex, Actinium Ac 225-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 3

HLX87 + Pertuzumab (HLX87 + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 2상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

21.15.GPC3-CAR T cells (21.15.GPC3-CAR T cells)

Atypical Teratoid Rhabdoid Tumor; Central Nervous System Rhabdoid Tumor · Hepatoblastoma

#Hepatoblastoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD3470 (AZD3470)

Advanced Solid Tumors That Are MTAP Deficient · Advanced Solid Tumors That Are MTAP Defi

#AdvancedSolidTumorsThatAreMTAPDe#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleGruppo Oncologico del Nord-OvestPhase 2

Vorbipiprant (Vorbipiprant)

Colorectal Cancer; Resectable Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
AntibodystalePETHEMA FoundationPhase 2

ibritumomab tiuxetan (ibritumomab tiuxetan)

Lymphoma · FRα

#FR#Antibody#Phase2#항체#면역항체+3
효능 ORR 89%임상시험 2상태 DISCONTINUED
ADCBiologicstaleAstraZenecaPhase 2

AZD0171 (AZD0171)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 34.9%임상시험 2상태 RECRUITING
ADCBiologicstaleDavid OhPhase 2

Etrumadenant (Etrumadenant)

Prostate Adenocarcinoma; Prostate Cancer · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicstaleSilverback TherapeuticsPhase 2

SBT6050 (SBT6050)

HER2-positive Breast Cancer; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 1%임상시험 2상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Abemaciclib (ARV-471 + Abemaciclib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
AntibodystaleRocheApproved

Rituximab Infusion (Rituximab Infusion)

Multiple Sclerosis · Nephrotic Syndrome

#NephroticSyndrome#Antibody#Approved#항체#면역항체+3
임상시험 2상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Dan222 + Niraparib (Dan222 + Niraparib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING

53 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기